Evidence map›Paper›PMID 24280728›Full record

ArticleHuman vaccines & immunotherapeutics2014

Coverage and predictors of vaccination against 2012/13 seasonal influenza in Madrid, Spain: analysis of population-based computerized immunization registries and clinical records.

Rodrigo Jiménez-García, María D Esteban-Vasallo, Cristina Rodríguez-Rieiro, Valentín Hernandez-Barrera, M A Felicitas Domínguez-Berjón, Pilar Carrasco Garrido, Ana Lopez de Andres, Moises Cameno Heras, Domingo Iniesta Fornies, Jenaro Astray-Mochales

Abstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Observational
  4. Article
  5. Causes and consequences of undervaccination in adults.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rodrigo Jiménez-GarcíaPreventive Medicine and Public Health Department; Rey Juan Carlos University; Madrid, Spain.
María D Esteban-VasalloDepartment of Epidemiology; Directorate of Health Promotion and Prevention; Ministry of Health; Community of Madrid; Madrid, Spain.
Cristina Rodríguez-RieiroPreventive Medicine and Public Health Department; Rey Juan Carlos University; Madrid, Spain.
Valentín Hernandez-BarreraPreventive Medicine and Public Health Department; Rey Juan Carlos University; Madrid, Spain.
M A Felicitas Domínguez-BerjónDepartment of Epidemiology; Directorate of Health Promotion and Prevention; Ministry of Health; Community of Madrid; Madrid, Spain.
Pilar Carrasco GarridoPreventive Medicine and Public Health Department; Rey Juan Carlos University; Madrid, Spain.
Ana Lopez de AndresPreventive Medicine and Public Health Department; Rey Juan Carlos University; Madrid, Spain.
Moises Cameno HerasDepartment of Prevention and promotion health; Directorate of Health Promotion and Prevention; Ministry of Health; Community of Madrid; Madrid, Spain.
Domingo Iniesta ForniesDepartment of Prevention and promotion health; Directorate of Health Promotion and Prevention; Ministry of Health; Community of Madrid; Madrid, Spain.
Jenaro Astray-MochalesDepartment of Epidemiology; Directorate of Health Promotion and Prevention; Ministry of Health; Community of Madrid; Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aim to determine 2012-13 seasonal influenza vaccination coverage. Data were analyzed by age group and by coexistence of concomitant chronic conditions. Factors associated with vaccine uptake were identified. We also analyze a possible trend in vaccine uptake in post pandemic seasons. We used computerized immunization registries and clinical records of the entire population of the Autonomous Community of Madrid, Spain (6,284,128 persons) as data source. A total of 871,631 individuals were vaccinated (13.87%). Coverage for people aged ≥ 65 years was 56.57%. Global coverage in people with a chronic condition was 15.7% in children and 18.69% in adults aged 15-59 years. The variables significantly associated with a higher likelihood of being vaccinated in the 2012-13 campaign for the age groups studied were higher age, being Spanish-born, higher number of doses of seasonal vaccine received in previous campaigns, uptake of pandemic vaccination, and having a chronic condition. We conclude that vaccination coverage in persons aged<60 years with chronic conditions is less than acceptable. The very low coverage among children with chronic conditions calls for urgent interventions. Among those aged ≥60 years, uptake is higher but still far from optimal and seems to be descending in post-pandemic campaigns. For those aged ≥65 years the mean percentage of decrease from the 2009/10 to the actual campaign has been 12%. Computerized clinical and immunization registers are useful tools for providing rapid and detailed information about influenza vaccination coverage in the population.

Indexed as

AdolescentAdultAgedAged, 80 and overAge FactorsChildChild, PreschoolCross-Sectional StudiesElectronic Health RecordsFemaleHumansInfantInfluenza, HumanInfluenza VaccinesMaleMiddle AgedInfluenza VaccinescoverageInfluenzaPredictorsRegistriesVaccine

Identifiers

PMID24280728
PMCPMC4185897

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.